Skip to Main Content

Paper Details

A molecular glue approach to control the half-life of CRISPR-based technologies.
bioRxiv
1
2023
AAV, CRISPR, CRISPRi, Cas9, amino acids, anti-CRISPRs, pomalidomide, response element, response elements, response-element, ubiquitin ligase
Author NameAffiliation
Vedagopuram SreekanthBroad Institute of MIT and Harvard
Vedagopuram SreekanthHarvard Medical School
Vedagopuram SreekanthBrigham and Women's Hospital
Donghyun LimBroad Institute of MIT and Harvard
Donghyun LimHarvard Medical School
Donghyun LimBrigham and Women's Hospital
Martin KampmannInstitute for Neurodegenerative Diseases, University of California san francisco
Martin Kampmann
Luca PinelloMassachusetts General Hospital
Luca PinelloBroad Institute of Harvard and MIT
Luca PinelloHarvard Medical School
David R LiuMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT
David R LiuHoward Hughes Medical Institute, Harvard University
David R LiuHarvard University
Benjamin L EbertBroad Institute of Harvard and MIT
Benjamin L EbertHoward Hughes Medical Institute, Dana-Farber Cancer Institute
Benjamin L EbertDana-Farber Cancer Institute
Amit ChoudharyBroad Institute of MIT and Harvard
Amit ChoudharyBrigham and Women's Hospital
Amit ChoudharyHarvard Medical School
Amit ChoudharyBroad Institute of MIT and Harvard
Amit ChoudharyBrigham and Women's Hospital
Amit ChoudharyHarvard Medical School
  • 1 - 23

Datasets